Thought leaders in the cloud.

Die Heinzelmännchen im Hintergrund

The last few years have seen pharma companies take a huge leap in moving their CRM systems to the Cloud. Pharma Relations, a leading German pharmaceutical publication, interviews Veeva Europe’s Director of Product Management, Arno Sosna, to get his perspectives on the advantages of Cloud-based CRM and to understand why Veeva CRM is taking the industry by storm.

Boehringer Ingelheim setzt auf Cloud-basiertes Veeva CRM und iRep

Der Pharma-Riese Boehringer Ingelheim wird künftig Veeva CRM über iRep für das iPad weltweit zur Unterstützung seiner für verschreibungspflichtige Medikamente zuständigen Teams einsetzen.

Boehringer Ingelheim uniformiza a nivel mundial todos los equipos comerciales de venta de medicamentos

Boehringer Ingelheim uniformiza a nivel mundial todos los equipos comerciales de venta de medicamentos con receta utilizando las aplicaciones de computación en nube, Veeva CRM e iRep.

Human Genome Sciences Selects C3i Inc to Provide Multilingual Helpdesk Support for its Veeva CRM Deployment in Europe

C3i Inc, a technology support and business process outsourcing (BPO) services provider for the life sciences industry, has been selected by Human Genome Sciences (HGS) to provide multilingual help desk support for their Veeva CRM deployment.

Veeva adds sample and promotion ordering to its cloud-based CRM

Announces more contract wins; integration with other software platforms in sales force automation
To hear Veeva’s VP of product marketing, Paul Shawah, tell it, Veeva (Pleasanton, CA) is now in a position to deliver a steady stream of enhancements, based mostly on customer demand and the attention span of its programmers. The latest: sample and promotional item ordering. “We already have such sample-management functions as electronic signature capture and inventory management; now sales reps can put in orders directly from Veeva CRM, and avoid the inconvenience of going to a sample-ordering portal and rekeying data,” he says. [...]

Apple Infiltrates $3.8 Trillion Market With IPad: Tech

Apple Inc. (AAPL), without much effort on its part, is making rapid headway in selling to corporations. After years of being the also-ran to Microsoft Corp. (MSFT) in the workplace, Apple has seen its iPad become a standard business tool.

“We haven’t seen a single pharma deploy on anything but the iPad,” said Matt Wallach, co-founder of Veeva Systems Inc., a Pleasanton, California-based maker of sales software for drug companies. “I’ve seen a lot of devices come and go over the years. Nothing touches the speed of adoption of the iPad.”

RIM’s New CEO Is Staying the Course

In this article, Bloomberg Businessweek turn the spotlight on how Apple’s iPad has dominated the first major new corporate hardware market in years, and Matt Wallach comments on the rapid uptake of the iPad among 95% of Veeva customers.

“It Looks Like You’re Trying to Use Word on an iPad”

In this article from Bloomberg Businessweek, Matt Wallach is interviewed on iRep and the iPad’s importance to the global pharma industry.

Industry’s Catch 22

The million-dollar question in pharmaceutical sales has to be: what does the future sales model look like? The answer at least for the moment, is that there is no one-size-fits-all selling model, which is why industry is finding it so difficult to forge ahead. As the pharma model is going through its first commercial and evolutionary transformation in 30 years, Dan Goldsmith, general manager, Veeva Europe, joins other industry thought leaders to discuss how the industry can successfully move towards a sales model that embraces partnerships and profits. PharmaTimes captured the discussion in its December issue with the article, Industry’s Catch 22.

The Race to Integrated Multichannel Marketing

For most pharmacos, multichannel marketing is nothing new. But reaping the full benefit of using multiple communication channels with customers is. Why? Few companies have integrated all those channels to have a common view of the customer, much less to maintain a continuous dialogue as the customer traverses channels. Fortunately, cloud-based CRM platforms such as Veeva CRM make this a non-issue. In the latest Pharmafocus Sales&Marketing Guide, our vice president, Product Marketing, Paul Shawah, shares his thoughts on how multichannel marketing can transform the traditional selling model.

Veeva and IMS Health Co-host Pharma CRM Excellence Seminar

Veeva and IMS’ co-hosted CRM Excellence Seminar in Spain on 17th November, in Barcelona shared insights on how pharma companies can implement an effective CRM strategy to help drive the commercial success of their organisation. PM Farma interviewed speakers Reinaldo Santos, practice manager, Veeva Europe and Jim Sales, director, Offering Management, CES Global Pharma Solutions at this event.

To Infinity and Beyond

Despite huge investments into CRM systems some pharma companies still struggle to get all of their staff to embrace and fully interact with them. Pf’s Iain Bate explores why, and what the future holds for technology in the industry, with insights included from Veeva’s general manager for Europe, Dan Goldsmith.

The Future is in the Cloud

Cloud computing is changing how IT services are used within pharma. Veeva assembled a group of pharma industry professionals involved in content and data management to discuss the business implications of this new approach.

Piggy in the Middle

The past few years have provided much soul searching for pharma. Where is innovation coming from? How should the industry communicate via social media? Is the role of sales representative dead? But perhaps surprisingly there has been little talk about how some of these changes will affect other intrinsic roles, such as the regional business manager. PharmaTimes speak with Dan Goldsmith, General Manager, Veeva Europe, amongst others to understand the role of the traditional RBM in the changing UK pharma marketplace.

Managing Physician Relationships in the Future

Physicians—just like other e-consumers—have come to expect that the information and services they seek be available instantly, around the clock, and with a high degree of personalisation. In this article, Dan Goldsmith, Veeva System’s General Manager, Europe, and Matt Wallach, Veeva’s Chief Strategy Officer, describe how pharmaceutical companies must adapt their sales and marketing practices to successfully reach and engage digitally-savvy physicians.

iPad 2 Brings Out Best of New iRep CRM/CLM Application

Veeva Systems’ recently launched iRep, combined with Apple’s iPad 2 Face Time, open exciting possibilities for life sciences. With iRep and Face Time reps can now be instantly connected face-to-face with other members of the commercial team during a meeting with a physician. “It’s like bringing an expert along for every sales call…truly amazing.”

The Real-time Rep Becomes a Reality

New mobile technology is paving the way for the emergence of the real-time rep. In this article, Dan Goldsmith, General Manager, Europe, Veeva Systems takes a close look at how the latest generation of mobile technology, combined with Customer Relationship Management (CRM) and Closed Loop Marketing (CLM) capabilities will help the pharma industry boost sales and marketing efficiency and effectiveness.

What Pharma Can Learn from the Use of KAM in Other Industries

Dan Goldsmith, general manager of Veeva Europe, and Patrick Hart, CRM partner at Accenture Management Consulting, discuss the significance of key account management in pharma and the lessons pharma can learn from other industries who have already taken this path successfully.

Veeva’s iRep Combines CRM and CLM on the Apple iPad

We know that iRep is a game-changer for the Pharmaceutical Sales & Marketing world. But you don’t need to take our word for it, Steve Niles from MedAdNews was at the iRep launch event in Philadelphia, follow his blog to read his comments, as well those of other members of the Pharma industry.

Commercial Advantages of Cloud-Based CRM Solutions for Pharma

PM Farma, Spain’s leading pharmaceutical magazine, interviewed Dan Goldsmith,General Manager, Europe, Veeva Systems to get his perspective on how pharma can gain competitive advantage and increase commercial effectiveness through the adoption of cloud-based CRM solutions for pharma.

CRM in the Cloud

Dan Goldsmith of Veeva Europe explains why multi-tenant SaaS technology — or cloud technology — is becoming the glue that enables life science businesses to remain close to patients, prescribers and payers and to do so more cost-effectively than ever before.